Compile Data Set for Download or QSAR
maximum 50k data
Found 102 for UniProtKB: O08786
LigandPNGBDBM50016425((S)-3-{(S)-2-[(S)-2-(2-{(S)-2-[(S)-2-tert-Butoxyca...)
Affinity DataKi:  0.191nMAssay Description:Binding affinity measured by inhibiting [3H]Boc[Nle28,31]CCK27-33 specific binding to Cholecystokinin receptor in mouse brain membranes at a KD conce...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
LigandPNGBDBM21147((3S)-3-[(2S)-2-[(2S)-2-{2-[(2S)-2-[(2S)-2-[(3S)-3-...)
Affinity DataKi:  0.300nMAssay Description:Potency in displacing [3H]propionyl-Cholecystokinin from mouse brain membranes.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
LigandPNGBDBM21147((3S)-3-[(2S)-2-[(2S)-2-{2-[(2S)-2-[(2S)-2-[(3S)-3-...)
Affinity DataKi:  0.491nMAssay Description:Binding affinity measured by inhibiting [3H]Boc[Nle28,31]CCK27-33 specific binding to Cholecystokinin receptor in mouse brain membranes at a KD conce...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
LigandPNGBDBM50002477((S)-3-{(S)-2-[(S)-2-tert-Butoxycarbonylamino-3-(1H...)
Affinity DataKi:  1.80nMAssay Description:Displacement of [3H]pentagastrin from Cholecystokinin receptor of mouse cerebral cortexMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
LigandPNGBDBM50226755(CHEMBL415630)
Affinity DataKi:  2nMAssay Description:Displacement of [3H]pentagastrin from Cholecystokinin receptor of mouse cerebral cortexMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
LigandPNGBDBM50024317(3-{2-[2-Amino-3-(1H-indol-3-yl)-propionylamino]-4-...)
Affinity DataKi:  3nMAssay Description:Displacement of [3H]pentagastrin from Cholecystokinin receptor of mouse cerebral cortexMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCholecystokinin receptor type A(Mus musculus)
The R. W. Johnson Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50073050((S)-1-(3-Amino-pentanoyl)-2,3-dihydro-1H-indole-2-...)
Affinity DataKi:  7nMAssay Description:Binding affinity of the compound in Cholecystokinin type A receptor binding assay (iv) in miceMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
LigandPNGBDBM50016424(CHEMBL216677 | N-(2-Amino-1-benzyl-ethyl)-3-{2-[2-...)
Affinity DataKi:  120nMAssay Description:Binding affinity measured by inhibiting [3H]Boc[Nle28,31]CCK27-33 specific binding to Cholecystokinin receptor in mouse brain membranes at a KD conce...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
LigandPNGBDBM21147((3S)-3-[(2S)-2-[(2S)-2-{2-[(2S)-2-[(2S)-2-[(3S)-3-...)
Affinity DataKi:  180nMAssay Description:Displacement of [3H]pentagastrin from Cholecystokinin receptor of mouse cerebral cortexMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
LigandPNGBDBM21147((3S)-3-[(2S)-2-[(2S)-2-{2-[(2S)-2-[(2S)-2-[(3S)-3-...)
Affinity DataKi:  180nMAssay Description:Displacement of [3H]pentagastrin from Cholecystokinin receptor of mouse cerebral cortexMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
LigandPNGBDBM50016426(3-{2-[2-(6-Amino-2-{2-[2-(2-tert-butoxycarbonylami...)
Affinity DataKi:  300nMAssay Description:Binding affinity measured by inhibiting [3H]Boc[Nle28,31]CCK27-33 specific binding to Cholecystokinin receptor in mouse brain membranes at a KD conce...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
LigandPNGBDBM50016421(3-{2-[2-(6-Amino-2-{2-[2-(2-tert-butoxycarbonylami...)
Affinity DataKi: >1.00E+3nMAssay Description:Binding affinity measured by inhibiting [3H]Boc[Nle28,31]CCK27-33 specific binding to Cholecystokinin receptor in mouse brain membranes at a KD conce...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
LigandPNGBDBM50226758(CHEMBL163010)
Affinity DataKi:  1.60E+3nMAssay Description:Displacement of [3H]pentagastrin from Cholecystokinin receptor of mouse cerebral cortexMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
LigandPNGBDBM50016422(3-{[9-[2-Amino-3-(4-sulfooxy-phenyl)-propionylamin...)
Affinity DataKi: >1.00E+4nMAssay Description:Binding affinity measured by inhibiting [3H]Boc[Nle28,31]CCK27-33 specific binding to Cholecystokinin receptor in mouse brain membranes at a KD conce...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
LigandPNGBDBM50016423(3-{2-[2-{[9-tert-Butoxycarbonylamino-3-butyl-2,5,8...)
Affinity DataKi: >1.00E+4nMAssay Description:Binding affinity measured by inhibiting [3H]Boc[Nle28,31]CCK27-33 specific binding to Cholecystokinin receptor in mouse brain membranes at a KD conce...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
LigandPNGBDBM50226754(CHEMBL2371390)
Affinity DataKi:  1.10E+4nMAssay Description:Displacement of [3H]pentagastrin from Cholecystokinin receptor of mouse cerebral cortexMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
LigandPNGBDBM50226757(CHEMBL352674)
Affinity DataKi:  2.40E+4nMAssay Description:Displacement of [3H]pentagastrin from Cholecystokinin receptor of mouse cerebral cortexMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
LigandPNGBDBM50226753(CHEMBL352070)
Affinity DataKi:  4.50E+4nMAssay Description:Displacement of [3H]pentagastrin from Cholecystokinin receptor of mouse cerebral cortexMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
LigandPNGBDBM50024320(CHEMBL32301 | [(S)-1-((S)-1-Carbamoyl-2-phenyl-eth...)
Affinity DataKi:  7.50E+4nMAssay Description:Displacement of [3H]pentagastrin from Cholecystokinin receptor of mouse cerebral cortexMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
LigandPNGBDBM50226756(CHEMBL163210)
Affinity DataKi:  5.20E+6nMAssay Description:Displacement of [3H]pentagastrin from Cholecystokinin receptor of mouse cerebral cortexMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
LigandPNGBDBM50226759(CHEMBL162600)
Affinity DataKi:  5.30E+6nMAssay Description:Displacement of [3H]pentagastrin from Cholecystokinin receptor of mouse cerebral cortexMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
LigandPNGBDBM50024321(3-{2-[2-(3-tert-Butoxycarbonylamino-propionylamino...)
Affinity DataKi:  6.00E+8nMAssay Description:Displacement of [3H]pentagastrin from Cholecystokinin receptor of mouse cerebral cortexMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
LigandPNGBDBM50226752(CHEMBL162388)
Affinity DataKi:  1.00E+9nMAssay Description:Displacement of [3H]pentagastrin from Cholecystokinin receptor of mouse cerebral cortexMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCholecystokinin receptor type A(Mus musculus)
The R. W. Johnson Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50284146(CHEMBL355608 | [(S)-1-[(S)-1-((R)-3-Benzyl-5-oxo-p...)
Affinity DataIC50:  14nMAssay Description:Concentration producing half-maximal inhibition of specific binding of [125I]- CCK-8 to CCK receptors on mouse pancreatic membranes (CCK-A)More data for this Ligand-Target Pair
In DepthDetails Article
TargetCholecystokinin receptor type A(Mus musculus)
The R. W. Johnson Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50284148(CHEMBL171310 | [(S)-1-[(S)-1-((R)-3-Benzyl-5-oxo-p...)
Affinity DataIC50:  46nMAssay Description:Concentration producing half-maximal inhibition of specific binding of [125I]- CCK-8 to CCK receptors on mouse pancreatic membranes (CCK-A)More data for this Ligand-Target Pair
In DepthDetails Article
TargetCholecystokinin receptor type A(Mus musculus)
The R. W. Johnson Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50284156(CHEMBL169174 | [(S)-1-[(S)-1-((S)-3-Benzyl-5-oxo-p...)
Affinity DataIC50:  64nMAssay Description:Concentration producing half-maximal inhibition of specific binding of [125I]- CCK-8 to CCK receptors on mouse pancreatic membranes (CCK-A)More data for this Ligand-Target Pair
In DepthDetails Article
TargetCholecystokinin receptor type A(Mus musculus)
The R. W. Johnson Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50287255(CHEMBL30821 | N-[2-(2-Guanidino-thiazol-4-ylmethyl...)
Affinity DataIC50:  120nMAssay Description:Inhibitory activity against Cholecystokinin type A receptorMore data for this Ligand-Target Pair
In DepthDetails Article
TargetCholecystokinin receptor type A(Mus musculus)
The R. W. Johnson Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50287234(3-(2-{3-[3-((R)-1-Methyl-2-oxo-5-phenyl-2,3-dihydr...)
Affinity DataIC50:  190nMAssay Description:Inhibitory activity against Cholecystokinin type A receptorMore data for this Ligand-Target Pair
In DepthDetails Article
TargetCholecystokinin receptor type A(Mus musculus)
The R. W. Johnson Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50287253(6-(2-{3-[3-((R)-1-Methyl-2-oxo-5-phenyl-2,3-dihydr...)
Affinity DataIC50:  190nMAssay Description:Inhibitory activity against Cholecystokinin type A receptorMore data for this Ligand-Target Pair
In DepthDetails Article
TargetCholecystokinin receptor type A(Mus musculus)
The R. W. Johnson Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50284147(CHEMBL354363 | [(S)-1-[(S)-1-((S)-3-Benzyl-5-oxo-p...)
Affinity DataIC50:  270nMAssay Description:Concentration producing half-maximal inhibition of specific binding of [125I]- CCK-8 to CCK receptors on mouse pancreatic membranes (CCK-A)More data for this Ligand-Target Pair
In DepthDetails Article
TargetCholecystokinin receptor type A(Mus musculus)
The R. W. Johnson Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50287265(CHEMBL406844 | {2-[3-(3-Piperidin-1-ylmethyl-pheno...)
Affinity DataIC50:  310nMAssay Description:Inhibitory activity against Cholecystokinin type A receptorMore data for this Ligand-Target Pair
In DepthDetails Article
TargetCholecystokinin receptor type A(Mus musculus)
The R. W. Johnson Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50287250(4-(2-{3-[3-((R)-1-Methyl-2-oxo-5-phenyl-2,3-dihydr...)
Affinity DataIC50:  330nMAssay Description:Inhibitory activity against Cholecystokinin type A receptorMore data for this Ligand-Target Pair
In DepthDetails Article
TargetCholecystokinin receptor type A(Mus musculus)
The R. W. Johnson Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50287251(CHEMBL262125 | N-[2-(2-Guanidino-thiazol-4-ylmethy...)
Affinity DataIC50:  330nMAssay Description:Inhibitory activity against Cholecystokinin type A receptorMore data for this Ligand-Target Pair
In DepthDetails Article
TargetCholecystokinin receptor type A(Mus musculus)
The R. W. Johnson Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50287256(6-(2-{3-[3-((R)-1-Methyl-2-oxo-5-phenyl-2,3-dihydr...)
Affinity DataIC50:  340nMAssay Description:Inhibitory activity against Cholecystokinin type A receptorMore data for this Ligand-Target Pair
In DepthDetails Article
TargetCholecystokinin receptor type A(Mus musculus)
The R. W. Johnson Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50287233(CHEMBL280980 | N-[2-(2-Guanidino-thiazol-4-ylmethy...)
Affinity DataIC50:  380nMAssay Description:Inhibitory activity against Cholecystokinin type A receptorMore data for this Ligand-Target Pair
In DepthDetails Article
TargetCholecystokinin receptor type A(Mus musculus)
The R. W. Johnson Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50287259(CHEMBL286908 | N-[2-(2-Guanidino-thiazol-4-ylmethy...)
Affinity DataIC50:  390nMAssay Description:Inhibitory activity against Cholecystokinin type A receptorMore data for this Ligand-Target Pair
In DepthDetails Article
TargetCholecystokinin receptor type A(Mus musculus)
The R. W. Johnson Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50287244(2-[2-Oxo-5-phenyl-3-(3-m-tolyl-ureido)-2,3-dihydro...)
Affinity DataIC50:  430nMAssay Description:Inhibitory activity against Cholecystokinin type A receptorMore data for this Ligand-Target Pair
In DepthDetails Article
TargetCholecystokinin receptor type A(Mus musculus)
The R. W. Johnson Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50284160(CHEMBL169178 | [(S)-1-[(S)-1-((S)-3-Benzyl-5-oxo-p...)
Affinity DataIC50:  430nMAssay Description:Concentration producing half-maximal inhibition of specific binding of [125I]- CCK-8 to CCK receptors on mouse pancreatic membranes (CCK-A)More data for this Ligand-Target Pair
In DepthDetails Article
TargetCholecystokinin receptor type A(Mus musculus)
The R. W. Johnson Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50284161((E)-N-[(S)-1-[(S)-1-((S)-3-Benzyl-5-oxo-piperazine...)
Affinity DataIC50:  520nMAssay Description:Concentration producing half-maximal inhibition of specific binding of [125I]- CCK-8 to CCK receptors on mouse pancreatic membranes (CCK-A)More data for this Ligand-Target Pair
In DepthDetails Article
TargetCholecystokinin receptor type A(Mus musculus)
The R. W. Johnson Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50287248(CHEMBL30430 | N-[2-(2-Guanidino-thiazol-4-ylmethyl...)
Affinity DataIC50:  560nMAssay Description:Inhibitory activity against Cholecystokinin type A receptorMore data for this Ligand-Target Pair
In DepthDetails Article
TargetCholecystokinin receptor type A(Mus musculus)
The R. W. Johnson Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50284151(((2S,5S)-1-{(S)-2-[(S)-2-tert-Butoxycarbonylamino-...)
Affinity DataIC50:  630nMAssay Description:Concentration producing half-maximal inhibition of specific binding of [125I]- CCK-8 to CCK receptors on mouse pancreatic membranes (CCK-A)More data for this Ligand-Target Pair
In DepthDetails Article
TargetCholecystokinin receptor type A(Mus musculus)
The R. W. Johnson Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50287238(6-{2-[2-Oxo-5-phenyl-3-(3-m-tolyl-ureido)-2,3-dihy...)
Affinity DataIC50:  650nMAssay Description:Inhibitory activity against Cholecystokinin type A receptorMore data for this Ligand-Target Pair
In DepthDetails Article
TargetCholecystokinin receptor type A(Mus musculus)
The R. W. Johnson Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50287236(CHEMBL286907 | N-[2-(2-Guanidino-thiazol-4-ylmethy...)
Affinity DataIC50:  720nMAssay Description:Inhibitory activity against Cholecystokinin type A receptorMore data for this Ligand-Target Pair
In DepthDetails Article
TargetCholecystokinin receptor type A(Mus musculus)
The R. W. Johnson Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50287272(CHEMBL33412 | [2-(4-{2-[3-(3-Piperidin-1-ylmethyl-...)
Affinity DataIC50:  740nMAssay Description:Inhibitory activity against Cholecystokinin type A receptorMore data for this Ligand-Target Pair
In DepthDetails Article
TargetCholecystokinin receptor type A(Mus musculus)
The R. W. Johnson Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50287254(CHEMBL281082 | N-{[2-(2-Guanidino-thiazol-4-ylmeth...)
Affinity DataIC50:  760nMAssay Description:Inhibitory activity against Cholecystokinin type A receptorMore data for this Ligand-Target Pair
In DepthDetails Article
TargetCholecystokinin receptor type A(Mus musculus)
The R. W. Johnson Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50284158(((2S,5S)-5-Benzyl-1-{(S)-2-[(S)-2-tert-butoxycarbo...)
Affinity DataIC50:  840nMAssay Description:Concentration producing half-maximal inhibition of specific binding of [125I]- CCK-8 to CCK receptors on mouse pancreatic membranes (CCK-A)More data for this Ligand-Target Pair
In DepthDetails Article
TargetCholecystokinin receptor type A(Mus musculus)
The R. W. Johnson Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50287246(4-{2-[2-Oxo-5-phenyl-3-(3-m-tolyl-ureido)-2,3-dihy...)
Affinity DataIC50:  900nMAssay Description:Inhibitory activity against Cholecystokinin type A receptorMore data for this Ligand-Target Pair
In DepthDetails Article
TargetCholecystokinin receptor type A(Mus musculus)
The R. W. Johnson Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50287271((3-{2-[2-(2,2-Diamino-vinyl)-thiazol-4-ylmethylsul...)
Affinity DataIC50: >1.00E+3nMAssay Description:Inhibitory activity against Cholecystokinin type A receptorMore data for this Ligand-Target Pair
In DepthDetails Article
TargetCholecystokinin receptor type A(Mus musculus)
The R. W. Johnson Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50287239(CHEMBL30656 | N-{[2-(2-Guanidino-thiazol-4-ylmethy...)
Affinity DataIC50:  1.09E+3nMAssay Description:Inhibitory activity against Cholecystokinin type A receptorMore data for this Ligand-Target Pair
In DepthDetails Article
TargetCholecystokinin receptor type A(Mus musculus)
The R. W. Johnson Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50287261((3-{2-[2-(2,2-Diamino-vinyl)-thiazol-4-ylmethylsul...)
Affinity DataIC50:  1.30E+3nMAssay Description:Inhibitory activity against Cholecystokinin type A receptorMore data for this Ligand-Target Pair
In DepthDetails Article
Displayed 1 to 50 (of 102 total ) | Next | Last >>
Jump to: